Clinician's Roundtable

Postsurgical wound complications can drastically impact patient outcomes, lead to preventable readmissions, and drive up healthcare costs. Hear from Dr. Karen Bauer as she explores the multifactorial risks that increase susceptibility to wound dehiscence and infection and provides proactive strategies to minimize complications and enhance healing. Dr. Bauer is a certified nurse practitioner and wound specialist at Emory Heart and Vascular Center in Atlanta.

The integration of near-infrared spectroscopy, bacterial fluorescence, and AI-powered imaging is accelerating precision in wound management. Discover how sensor technology, smart bandages, and real-time data from wearables are standardizing care, reducing variability, and enabling faster clinical decision-making with Ms. Kara Couch. She's a certified wound care nurse practitioner, the Director of Wound Care Services at George Washington University Hospital, and an Associate Research Professor of Surgery at the George Washington University.

Effective wound care goes far beyond just surface evaluation. This expert-led program explores advanced wound assessment strategies, including measurement techniques, drainage evaluation, and recognition of signs of infection. Tune in to hear from Ms. Kara Couch as she explores best practices for optimal wound care. Ms. Couch is a certified wound care nurse practitioner, the Director of Wound Care Services at George Washington University Hospital, and an Associate Research Professor of Surgery at the George Washington University.

Successful surgical wound care goes beyond closure—it’s also about minimizing complications, reducing readmissions, and aligning with patient-reported outcomes like pain control and daily activity readiness. Hear from Ms. Kara Couch as she explores how standardization, documentation, and evidence-based strategies drive better healing and patient satisfaction. Ms. Couch is a certified wound care nurse practitioner, the Director of Wound Care Services at George Washington University Hospital, and an Associate Research Professor of Surgery at the George Washington University.

With colorectal cancer screening rates still falling short of national goals, new strategies are gaining attention—particularly blood-based tests. A recent modeling study compared this emerging tool to other options like stool-based testing and colonoscopy, exploring its potential as a colorectal cancer screening method and barriers to its adoption. Joining Dr. Charles Turck to break down the study and discuss the role of blood-based screening tests in shaping the colorectal cancer screening landscape is Dr. Samuel Muench. Dr. Muench is a board-certified and fellowship-trained gastroenterologist at Capital Digestive Care in Washington, DC.

New insights into B-cell dysregulation are reshaping our understanding of IgA nephropathy (IgAN), and the BAFF/APRIL pathway in particular is being studied for its role in driving immune complex formation, glomerular injury, and disease progression. Joining Dr. Charles Turck to discuss B-cell dysregulation and its potential impacts on the IgAN treatment landscape is Dr. Jonathan Barratt. Dr. Barratt is the Mayor Professor of Renal Medicine at the University of Leicester in the United Kingdom, where he also leads the Renal Research Group.

Early detection of IgA nephropathy (IgAN) is often missed due to its subtle presentation, leading to delays in critical care. However, knowing the red-flag signs and symptoms to look out for can help improve timely diagnosis and intervention. Joining Dr. Gates Colbert to discuss practical strategies for identifying IgAN early are Drs. Meghan Sise and Ellie Kelepouris. Dr. Sise is the Director of Onconephrology at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School, and Dr. Kelepouris is the Director of the Outpatient Dialysis Program and a Professor of Clinical Medicine at Penn Medicine.

Over the past several decades, IgA nephropathy (IgAN) has gone from being regarded as relatively harmless to being recognized as a progressive, high-risk disease. With this new understanding, early diagnosis and strategic intervention are more critical than ever. Tune in as Dr. Suneel Udani, a nephrologist with Nephrology Associates of Northern Illinois, joins Dr. Brian McDonough to examine the key factors in detecting and treating IgAN.

With colorectal cancer screening rates still lagging, blood-based liquid biopsy tests are emerging as a promising strategy to improve adherence, especially among those reluctant to undergo traditional screening methods. However, these tests come with some challenges that may limit their real-world effectiveness. Joining Dr. Charles Turck to discuss these potential benefits and barriers is Dr. Brennan Spiegel, a Professor of Medicine in Public Health and the Director of Health Services Research at Cedar-Sinai in Los Angeles.

Patients with pulmonary fibrosis often face anxiety and emotional distress that go unadressed during their care. Given this unmet need, a digital cognitive behavioral therapy (CBT) platform was designed to support emotional wellbeing alonside medical treatment. Mr. Ryan Quigley sits down with Drs. Jessica Shull and Joshua Solomon, who presented at the 2025 American Thoracic Society International Conference to explore how this platform may enhance quality of life, support therapy adherence, and integrate into routine care. Dr. Shull is the Director of Digital Health and a Clinical Science Liaison at Vicore Pharma, and Dr. Solomon is a Professor of Medicine in Pulmonary Care and the Director of the Interstitial Lung Disease Program at National Jewish Health.